Buradasınız

Anasayfa » Content

Hemodiyaliz Hastasında Koroner Anjiyografi Sonrası Gelişen Kolesterol Embolizasyon Sendromu

Cholesterol Embolization Syndrome Developing after Coronary Angiography in a Hemodialysis Patient

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2014
DOI: 
10.5262/tndt.2014.1003.12

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Cholesterol Embolization Syndrome (CES) is a systemic disorder due to cholesterol crystal embolization from atherosclerotic plaques of the aorta and its major branches to the small arterioles, resulting in local ischemia and organ damage. The diagnosis is mostly missed, especially in dialysis patients. There is no definite treatment available and the mortality is relatively high. We present a hemodialysis patient with cholesterol embolization syndrome who developed discoloration of the toes and necrotic ulcers after coronary angiography and whose diagnosis was confirmed with skin biopsy, and discuss the case with literature information.
Bookmark/Search this post with
Abstract (Original Language): 
Kolesterol embolizasyon sendromu (KES), aorta ve major dallarının aterosklerotik plaklarından kaynaklanan kolesterol kristallerinin küçük arteriolleri tıkaması ile meydana gelen sistemik bir bozukluk olup, lokal iskemi ve organ hasarı ile sonuçlanır. Tanı çoğu zaman özellikle diyaliz hastalarında atlanmakta olup kesin bir tedavisi yoktur ve mortalitesi oldukça yüksektir. Burada koroner anjiyografi sonrası ayak parmaklarında morarma ve nekrotik ülsere yaraları gelişen ve cilt biyopsisi ile tanısı doğrulanan kolesterol embolizasyon sendromu olan hemodiyaliz hastası literatür bilgileri ile tartışılmıştır.
FULL TEXT (PDF): 
PDF icon arastirmax-hemodiyaliz-hastasinda-koroner-anjiyografi-sonrasi-gelisen-kolesterol-embolizasyon-sendromu.pdf
  • 3
248
251
  • Turkish

REFERENCES

References: 

1. Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E,
Maiorca R: Cholesterol crystal embolism: A recognizable cause of
renal disease. Am J Kidney Dis 2000; 6: 1089-1109
2. Park S, Schroeter A, Park Y, Forston J: Purple toes and livedo
reticularis in a patient with cardio-vascular disease taking coumadin.
Arch Dermatol 1993; 129: 777-780
3. Harrington JT, Sommers SC, Kassirer JP: Atheromatous emboli
with progressive renal failure. Ann Intern Med 1968; 68: 152-160
4. Mayo RR, Schwartz RD: Redefining the incidence of clinically
detectable atheroembolism. Am J Med 1996; 100: 524-529
5. Carvajal JA, Anderson WR, Weiss L, Grismer J, Berman R:
Atheroembolism: An etiologic factor in renal insufficiency,
gastrointestinal hemorrhages and peripheral vascular diseases. Arch
Intern Med 1967; 119: 593-599
6. Modi KS, Rao VK: Atheroembolic renal disease. J Am Soc Nephrol
2001; 12: 1781-1787
7. Gillerot G, Sempoux C, Pirson Y, Devuyst O: Which type of
dialysis in patients with cholesterol crystal embolism? Nephrol Dial
Transplant 2002; 17: 156-158
8. Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita
A; Cholesterol Embolism Study(CHEST) Investigators: The
incidence and risk factors of cholesterol embolization syndrome, a
complication of cardiac catheterization: A prospective study. J Am
Coll Cardiol 2003; 42(2):211-216
9. Machino-Ohtsuka T, Seo Y, Ishizu T, Sekiguchi Y, Sato A, Tada
H, Watanabe S, Aonuma K: Combined assessment of carotid
vulnerable plaque, renal insufficiency, eosinophilia, and hs-CRP for
predicting risky aortic plaque of cholesterol crystal embolism. Circ
J 2010; 74:51-5810. Funabiki K, Masuoka H, Shimizu H, Emi Y, Mori T, Ito M,
Nakano T: Cholesterol crystal embolization (CCE) after cardiac
catheterization. A case report and a review of 36 cases in the
Japanese literature. Jpn Heart J 2003; 44(5):767-774
11. Fine MJ, Kapoor W, Falanga V: Cholesterol crystal embolization:
A review of 221 cases in the English literature. Angiology 1987;
38:769
12. Lye WC, Cheah JS, Sinniah R: Renal cholesterol embolic disease.
Case report and review of the literature. Am J Nephrol 1993;
13:489-493
13. Piccoli GB, Fenoglio R, Colla L, Bilucaglia D, Mezza E, Burdese M,
Bermond F, Segoloni GP: Cholesterol crystal embolism syndrome
in dialysis patients: An emerging clinical diagnosis? Blood Purif
2006; 24(5-6):433-438
14. Gittinger JW Jr, Kershaw GR: Retinal cholesterol emboli
in the diagnosis of renal atheroembolism. Arch Intern Med
1998;158(11):1265-1267
15. Elinav E, Chajek-Shaul T, Stern M: Improvement in cholesterol
emboli syndrome after iloprost therapy. BMJ 2002;324(7332):268-
269
16. Boero R, Pignataro A, Rollino C, Quarello F: Do corticosteroids
improve survival in acute renal failure due to cholesterol
atheroembolism? Nephrol Dial Transplant 2000;15(3):441

Thank you for copying data from http://www.arastirmax.com